Kathleen A Stringer
Albert B Prescott Professor
Professor of Clinical and Translational Pharmacy
College of Pharmacy and Professor of Internal Medicine
[email protected]

Available to mentor
Kathleen A Stringer
Professor
  • About
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
    • Qualifications
    • Fellow
      University at Buffalo, State University of New York, Buffalo, 2024
    • Fellow
      University of Colorado HSC, Denver, 1996
    • Resident
      University of Illinois at Chicago, Clinical Pharmacy, 1986
    • PharmD
      University of Michigan, Ann Arbor, 1985
    Center Memberships
    • Center Member
      Center for Computational Medicine and Bioinformatics
    • Center Member
      Precision Health Initiative
    • Center Member
      Samuel and Jean Frankel Cardiovascular Center
    Research Overview

    metabolomics, pharmacometabolomics, critical care, sepsis, ARDS, experimental therapeutics, pharmacotherapy, biomarker discovery

    Recent Publications See All Publications
    • Preprint
      Alveolar metabolite availability facilitates secondary infection by Pseudomonas aeruginosa in acutely injured lungs
      Baker JM, Flott TL, McLellan LA, Bustos IG, Guerrero JL, Mendez LM, Petouhoff AM, Ranjan P, Metcalf JD, McDonald RA, Falkowski NR, He Y, Cala MP, Huffnagle GB, Sjoding MW, Reyes LF, Stringer KA, Dickson RP. bioRxiv, DOI:10.1101/2024.12.18.629020
    • Proceeding / Abstract / Poster
      The impact of differential nutrient availability during acute lung injury on Pseudomonas aeruginosa growth
      Baker J, Flott T, Mclellan L, Falkowski N, Huffnagle G, Stringer K, Dickson R. 2024 Sep 14; pa2396 DOI:10.1183/13993003.congress-2024.pa2396
    • Journal Article
      Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221.
      Chen C-S, Zirpoli G, Budd GT, Barlow WE, Pusztai L, Hortobagyi GN, Albain KS, Godwin AK, Thompson A, Henry NL, Ambrosone CB, Stringer KA, Hertz DL. Cancer Chemother Pharmacol, 2024 Aug; 94 (2): 311 - 321. DOI:10.1007/s00280-024-04680-6
      PMID: 38814343
    • Proceeding / Abstract / Poster
      Acetate, A Gut Microbial Metabolite, Is Elevated in Experimental Sepsis and Correlates With Disease Severity
      Adame MD, Baker JM, Falkowski NR, McDonald RA, Petouhoff AM, Stringer KA, Dickson RP. 2024 May; a3515 - a3515. DOI:10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a3515
    • Proceeding / Abstract / Poster
      Differential Nutrient Availability During Acute Lung Injury Enhances Growth of Pseudomonas Aeruginosa
      Baker JM, Flott TL, McLellan LA, Falkowski NR, Huffnagle GB, Stringer KA, Dickson RP. 2024 May; a6811 - a6811. DOI:10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a6811
    • Journal Article
      Database screening as a strategy to identify endogenous candidate metabolites to probe and assess mitochondrial drug toxicity.
      De la Rosa MVG, Patel D, McCann MR, Stringer KA, Rosania GR. Sci Rep, 2023 Dec 12; 13 (1): 22013 DOI:10.1038/s41598-023-49443-0
      PMID: 38086883
    • Journal Article
      Kidney function as a key driver of the pharmacokinetic response to high-dose L-carnitine in septic shock.
      Jennaro TS, Puskarich MA, Flott TL, McLellan LA, Jones AE, Pai MP, Stringer KA. Pharmacotherapy, 2023 Dec; 43 (12): 1240 - 1250. DOI:10.1002/phar.2882
      PMID: 37775945
    • Journal Article
      Plasma metabolomics and quantitative interstitial abnormalities in ever-smokers.
      Choi B, San José Estépar R, Godbole S, Curtis JL, Wang JM, San José Estépar R, Rosas IO, Mayers JR, Hobbs BD, Hersh CP, Ash SY, Han MK, Bowler RP, Stringer KA, Washko GR, Labaki WW. Respir Res, 2023 Nov 4; 24 (1): 265 DOI:10.1186/s12931-023-02576-2
      PMID: 37925418